ClinicalTrials.Veeva

Menu

Fibrinogen Concentrate and Placenta Acreta Spectrum

B

Bakirkoy Dr. Sadi Konuk Training and Research Hospital

Status

Completed

Conditions

Placenta Accreta
Obstetric Anesthesia Problems

Treatments

Procedure: the group without fibrinogen concentrate (GNF) , the group with fibrinogen concentrate (GF)

Study type

Interventional

Funder types

Other

Identifiers

NCT05938062
2023-02

Details and patient eligibility

About

The aim of this study is to evaluate the relationship between fibrinogen use and bleeding in patients who underwent cesarean section with a prediagnosis of PAS.

The key question(s) it aims to answer are:

[Does the use of fibrinogen concentrate reduce bleeding in PAS patients?] Patients who had a cesarean section with a pre-diagnosis of PAS were analyzed retrospectively. The choice of anesthesia applied to the patients and the relationship between the use of blood products and bleeding were evaluated.

Full description

Our study was designed as a retrospective randomized study. Patients aged 20-50 years and >34 weeks of gestation who accepted the birth with a cesarean section with a pre-diagnosis of PAS were evaluated retrospectively.

examined. were randomized into 2 groups, 53 patients in each group: group1: GNF : the group without fibrinogen concentrate

Group 2: GF: the group with fibrinogen concentrate

Enrollment

146 patients

Sex

Female

Ages

20 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 20-50 years PAS pre-diagnosed pregnant women
  • >34 weeks of pregnancy
  • Those with normal renal functions

Exclusion criteria

  • Patients with renal insufficiency
  • Those with <34 weeks of gestation
  • Pregnant women with missing data

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

146 participants in 2 patient groups

grup 1: the group without fibrinogen concentrate (GNF)
Experimental group
Description:
grup 1: the group without fibrinogen concentrate (GNF)
Treatment:
Procedure: the group without fibrinogen concentrate (GNF) , the group with fibrinogen concentrate (GF)
Grup 2: the group with fibrinogen concentrate
Experimental group
Description:
Grup 2: the group with fibrinogen concentrate
Treatment:
Procedure: the group without fibrinogen concentrate (GNF) , the group with fibrinogen concentrate (GF)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems